CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Drugmakers GlaxoSmithKline and Boehringer Ingelheim announced Tuesday that they have agreed to allow the widespread manufacture of cheap generic versions of their patented anti-HIV drugs in South Africa. In an out-of-court settlement with AIDS activists the companies agreed to grant more licenses to generic firms to produce and import antiretroviral drugs. The deal comes after South Africa's Competition Commission found the companies guilty in October of anticompetitive behavior over the sale of AIDS drugs and recommended to the Competition Tribunal--an enforcement body--that they be fined and required to allow the manufacture of generics. The commission said today it will not fine Glaxo for anticompetitive behavior, and a similar agreement is being discussed with Boehringer. Activist group Treatment Action Campaign said, under the terms of the deal, the two firms would charge no more than a 5% royalty fee on the sales of generic drugs in South Africa. According to a Glaxo spokesman, the company will extend a voluntary license it granted to local firm Aspen Pharmacare in October 2001 for the production of antiretrovirals to other companies. A second firm, Thembalami Pharmaceuticals, has already been offered another license. Glaxo would consider applications for another two possible licenses for producing copies of its drugs AZT and 3TC. Boehringer will grant three licenses for the manufacture and import of Viramune to prevent mother-to-child HIV transmission. The first license has already gone to Aspen.
From our Sponsors
Most Popular
31 Period Films of Lesbians and Bi Women in Love That Will Take You Back
December 09 2024 1:00 PM
18 of the most batsh*t things N.C. Republican governor candidate Mark Robinson has said
October 30 2024 11:06 AM
True
After 20 years, and after tonight, Obama will no longer be the Democrats' top star
August 20 2024 12:28 PM
Trump ally Laura Loomer goes after Lindsey Graham: ‘We all know you’re gay’
September 13 2024 2:28 PM
Melania Trump cashed six-figure check to speak to gay Republicans at Mar-a-Lago
August 16 2024 5:57 PM
These 13 major companies caved to the far right and stopped DEI programs
January 24 2025 1:11 PM
True
Latest Stories
If Trump can rename the Gulf, why can't we rename ourselves?
February 05 2025 7:00 AM
What can trans people do about Trump’s executive orders? Be plaintiffs, says Lambda Legal
February 05 2025 6:00 AM
Lawsuit challenges Trump's executive order targeting gender-affirming care
February 04 2025 7:58 PM
Fearless + Fighting Back: Lambda Legal’s plan to protect LGBTQ+ and HIV rights
February 04 2025 6:04 PM
e.l.f. Beauty CEO defends DEI: 'Our diversity is a key competitive advantage'
February 04 2025 5:19 PM
Trump moves to abolish Education Department amid push against 'wokeness'
February 04 2025 2:50 PM
Donald Trump's DOT will prioritize areas with higher 'marriage and birth rates'
February 04 2025 1:42 PM
Kim Davis is back in court because she doesn't want to pay a gay couple
February 04 2025 12:27 PM
Amber Ruffin to headline 2025 White House Correspondents’ Dinner. But, will Trump attend?
February 04 2025 11:49 AM
Transgender author Jennifer Finney Boylan: The fight is not over
February 04 2025 11:24 AM